1,940 Shares in Balchem Co. (NASDAQ:BCPC) Bought by CIBC Asset Management Inc

CIBC Asset Management Inc purchased a new stake in shares of Balchem Co. (NASDAQ:BCPCFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,940 shares of the basic materials company’s stock, valued at approximately $289,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Cardinal Capital Management raised its holdings in shares of Balchem by 0.4% during the 4th quarter. Cardinal Capital Management now owns 19,539 shares of the basic materials company’s stock valued at $2,922,000 after buying an additional 79 shares in the last quarter. Signaturefd LLC raised its stake in shares of Balchem by 123.0% during the fourth quarter. Signaturefd LLC now owns 165 shares of the basic materials company’s stock worth $25,000 after acquiring an additional 91 shares in the last quarter. Allworth Financial LP lifted its holdings in shares of Balchem by 17.8% in the 4th quarter. Allworth Financial LP now owns 953 shares of the basic materials company’s stock worth $142,000 after acquiring an additional 144 shares during the last quarter. Evergreen Capital Management LLC boosted its stake in shares of Balchem by 8.9% in the 3rd quarter. Evergreen Capital Management LLC now owns 1,905 shares of the basic materials company’s stock valued at $236,000 after purchasing an additional 156 shares in the last quarter. Finally, Principal Securities Inc. purchased a new stake in shares of Balchem in the 4th quarter valued at $28,000. Institutional investors own 87.91% of the company’s stock.

Insiders Place Their Bets

In related news, Director David B. Fischer sold 5,000 shares of the business’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $152.98, for a total transaction of $764,900.00. Following the transaction, the director now owns 9,009 shares in the company, valued at $1,378,196.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, SVP Michael Robert Sestrick sold 1,929 shares of the business’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $154.45, for a total transaction of $297,934.05. Following the sale, the senior vice president now owns 4,878 shares in the company, valued at approximately $753,407.10. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director David B. Fischer sold 5,000 shares of Balchem stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $152.98, for a total transaction of $764,900.00. Following the transaction, the director now directly owns 9,009 shares of the company’s stock, valued at $1,378,196.82. The disclosure for this sale can be found here. Company insiders own 1.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. HC Wainwright boosted their price target on shares of Balchem from $167.00 to $170.00 and gave the stock a “buy” rating in a research note on Monday, May 6th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research note on Friday, May 10th.

Get Our Latest Research Report on Balchem

Balchem Trading Down 0.8 %

BCPC opened at $151.03 on Tuesday. Balchem Co. has a one year low of $110.74 and a one year high of $159.52. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.61 and a quick ratio of 1.72. The business has a 50 day simple moving average of $150.24 and a two-hundred day simple moving average of $146.89. The firm has a market capitalization of $4.90 billion, a price-to-earnings ratio of 42.66, a PEG ratio of 3.59 and a beta of 0.70.

Balchem (NASDAQ:BCPCGet Free Report) last announced its earnings results on Friday, May 3rd. The basic materials company reported $0.89 EPS for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.05). The business had revenue of $239.66 million for the quarter, compared to the consensus estimate of $234.12 million. Balchem had a net margin of 12.35% and a return on equity of 11.03%. Analysts predict that Balchem Co. will post 3.86 EPS for the current year.

Balchem Profile

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Further Reading

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPCFree Report).

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.